Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 4Terminated 2Recruiting 2Withdrawn 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 113Myeloid 29Lymphoid 16Classical hematology 3Sarcoma 2Plasma cell 2Head & Neck 2Breast 2Thoracic 1Gastrointestinal 1Dermatologic 1CNS 1

Conditions

Breast Neoplasms 2Neoplasms 1Gastrointestinal Neoplasms 1

Interventions

Fulvestrant 78pembrolizumab 77Carboplatin 73Capecitabine 69Trastuzumab 66Letrozole 62Cyclophosphamide 61Paclitaxel 60Specimen Handling 52pertuzumab 48Docetaxel 48abemaciclib 46ribociclib 44Anastrozole 35130-nm albumin-bound paclitaxel 35trastuzumab deruxtecan 34Magnetic Resonance Spectroscopy 34Tamoxifen 33Blood Specimen Collection 33sacituzumab govitecan 31exemestane 31Biopsy 31Gemcitabine 30Epirubicin 29palbociclib 28Surveys and Questionnaires 27Injections 27Drug Therapy 27pyrotinib 26eribulin 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Azacitidine × Breast × Clear all
NCT04891068 2026-01-14

BRE-04

University of Illinois at Chicago

Phase 2 Recruiting
40 enrolled
Breast

Breast Neoplasms

NCT05381038 2025-09-23

Optimizing and Personalising Azacitidine Combination Therapy for Treating Solid Tumours QPOP and CURATE.AI

National University Hospital, Singapore

Phase 1/2 Recruiting
10 enrolled
BreastGastrointestinal

Breast Neoplasms, Gastrointestinal Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡